Business
New mRNA vaccine could reduce the recurrence and spread of skin cancer - NPR

What the report says
Merck and Moderna announced a successful late-stage trial for a melanoma vaccine. NPR's Leila Fadel talks to Dr. Robert Vonderheide of Penn Medicine and the American Association for Cancer Research.
Loading debate for this article…
Other publishers covering this story
No additional verified coverage is currently clustered with this report.

Smallholder farmers to get relief from Equity GroupThe Observer
Miss Tourism East Africa Delegates Tour Kasubi Tombs, Buganda Heritage Sites Ahead of Kampala Grand FinaleWatchdog Uganda
Verto CEO Explains Why Compliance is Becoming Fintech’s Competitive Edge in AfricaNile Post
Ambassador Ababu Namwamba Rallies Miss Tourism East Africa Delegates to Promote Region’s Hidden GemsWatchdog Uganda
Zam Zam Godana Crowned Miss Tourism East Africa As Uganda’s Shakira Okoobah Claims Runner-Up SpotWatchdog Uganda